An IL-2 mutein increases regulatory T cell suppression of dendritic cells via IL-10 and CTLA-4 to promote T cell anergy

Braxton L. Jamison,Matthew Lawrance,Chun Jing Wang,Hannah A. DeBerg,Lauren J. Ziegler,David M. Sansom,Marc A. Gavin,Lucy S.K. Walker,Daniel J. Campbell
DOI: https://doi.org/10.1016/j.celrep.2024.114938
IF: 8.8
2024-11-03
Cell Reports
Abstract:Regulatory T (TR) cell expansion by interleukin-2 (IL-2) muteins is a promising therapy for autoimmune and inflammatory diseases. Jamison et al. show that IL-2 mutein-stimulated TR cells are highly activated and inhibit dendritic cell function via CTLA-4 and IL-10, leading to induction of anergic phenotype T cells in an autoimmune disease model.
cell biology
What problem does this paper attempt to address?